Development therapeutic system by exosomal DDS of nucleic acid drugs
-
- Ohno Shi-ichiro
- Department of Molecular Pathology, Tokyo medical university
-
- Takanashi Masakatsu
- Department of Molecular Pathology, Tokyo medical university
-
- Kuroda Masahiko
- Department of Molecular Pathology, Tokyo medical university
Bibliographic Information
- Other Title
-
- エクソソームによる核酸DDSの開発
- エクソソーム ニ ヨル カクサン DDS ノ カイハツ
Search this article
Abstract
A variety of cells release phospholipid membrane vesicles that are thought to play key roles in cell-cell communication, antigen presentation, and the spread of infectious agents. The membrane vesicles derived from the late endosomes called Exosomes. The various proteins, messenger RNAs (mRNAs) and microRNAs (miRNAs) carried by the exosomes to the cells in remote locations like a message in a bottle. The form to be protected encapsulated miRNA from ribonuclease (RNase) in the body fluid is ideal carrier for nucleic acid drugs. In addition, since the exosomes is constructed by self-component, the antigenicity and toxicity are expected to be low. It's extremely important property in carrier for drug delivery. This review presents an overview of the potential roles of exosomes with respect to carrier for miRNA delivery system.
Journal
-
- Drug Delivery System
-
Drug Delivery System 29 (2), 134-139, 2014
THE JAPAN SOCIETY OF DRUG DELIVERY SYSTEM
- Tweet
Details 詳細情報について
-
- CRID
- 1390001204642781440
-
- NII Article ID
- 130004495150
-
- NII Book ID
- AN10084591
-
- ISSN
- 18812732
- 09135006
-
- NDL BIB ID
- 025370508
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed